Biolidics Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SGD 0.041 million compared to SGD 1.08 million a year ago. Net loss was SGD 0.76 million compared to SGD 0.343 million a year ago.

Basic loss per share from continuing operations was SGD 0.001 compared to SGD 0.0007 a year ago. Diluted loss per share from continuing operations was SGD 0.001 compared to SGD 0.0007 a year ago.